Purchase Order 36C26225P2217
- Not listed
- Pantherx Specialty, LLC, a Pittsburgh-based specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order valued at $10,896.98 on December 8, 2025, by the Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract covers the emergency procurement of TARPEYO (budesonide) 4mg medication, with an ultimate completion date of January 7, 2026. There was no set-aside designation associated with...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract, valued at $10,896.98, is for the supply of TARPEYO 4MG (NDC 81749-0004-01), an emergency pharmaceutical product, to the VA's Veterans Integrated Service Network (VISN) 2. The contract has an ultimate completion date of July 30, 2025. Pantherx Specialty is the prime contractor,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for TARPEYO 4mg (budesonide), a specialty pharmaceutical product used to treat immunoglobulin A nephropathy in veterans. The contract, valued at $10,896.98, was awarded on November 10, 2025, with an ultimate completion date of December 10, 2025. The award carries no set-aside designation and will be...
- This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
- This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the delivery of TARPEYO 4mg (NDC 81749-0004-01), an emergency medical product, with a ceiling value of $10,896.98 and a period of performance ending on August 13, 2025. This contract does not have a...
- The U.S. Department of Veterans Affairs, specifically Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for emergency TARPEYO (budesonide) 4mg pharmaceutical supplies for the New York Harbor region. The contract, valued at $10,896.98, was awarded on December 9, 2025, with an ultimate completion date of January 8, 2026. No set-aside designation was applied to this procurement. Pantherx...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO 4MG, a specialized pharmaceutical product, to the VA's New York Harbor healthcare system. The contract has a ceiling value of $10,896.98 and a period of performance through July 31, 2025. The contract does not have a set-aside designation. Pantherx...
- This federal contract award, with a ceiling value of $85,242.15, was issued by the Department of Veterans Affairs Veterans Integrated Service Network 16 to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is a firm fixed price purchase order for the supply of the drug Ruzurgi (amifampridine 10mg) to VA facilities within VISN 16. This contract supports the medical needs of veterans obtaining care through the VA health system. No set-aside designation...
- This is a $10,897.20 firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG CAPSULES, a medication used to treat rare diseases, to various VA healthcare facilities under the Veterans Integrated Service Network 2. Pantherx Specialty has received multiple federal purchase orders from the Department of Veterans...
The Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) awarded a $30,275.65 firm fixed-price purchase order to Pantherx Specialty, LLC on September 16, 2025, for emergency pharmaceutical products. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, and will be performed at the contractor's location in Pittsburgh, Pennsylvania. Pantherx Specialty, LLC, operating as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, specializes in providing rare disease and customized pharmaceutical solutions to federal healthcare agencies. This award represents a typical engagement within Pantherx Specialty's established service model for the VA, where the contractor has consistently delivered specialized and emergency prescription medications through firm fixed-price purchase orders. The company's expertise in rare disease pharmaceuticals and emergency medication fulfillment aligns with VISN 22's mission to provide integrated healthcare services to veterans across its service territory. Given the emergency nature of the order and the short performance timeline, this contract reflects the urgent pharmaceutical needs that the VA must fulfill to support veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 9/16/25 |